Molecular responses to therapeutic proteasome inhibitors in multiple myeloma patients are donor-, cell type- and drug-dependent

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Eleni-Dimitra Papanagnou, Evangelos Terpos, Efstathios Kastritis, Issidora S. Papassideri, Ourania E. Tsitsilonis, Meletios A. Dimopoulos, Ioannis P. Trougakos

Journal title: Oncotarget

Journal number: 9/25

Journal publisher: Impact Journals

Published year: 2018

DOI identifier: 10.18632/oncotarget.24882

ISSN: 1949-2553